Table 3.
Effect of dulaglutide and liraglutide on DTSQs and eating behavior
| Dulaglutide | Liraglutide | ||||||
|---|---|---|---|---|---|---|---|
| Baseline | 24 weeks | p1 value | Baseline | 24 weeks | p1 value | p2 value | |
| DTSQ scores | |||||||
| 1. Current treatment | 5.36 ± 0.67 | 5.36 ± 1.21 | 0.562 | 4.82 ± 1.08 | 4.91 ± 0.54 | 0.898 | 0.847 |
| 2. Hyperglycemia | 3.36 ± 2.01 | 2.91 ± 1.97 | 0.606 | 2.45 ± 1.92 | 4.18 ± 1.47 | 0.040a | 0.034a |
| 3. Hypoglycemia | 1.18 ± 1.66 | 1.18 ± 1.60 | 0.898 | 1.73 ± 1.79 | 1.18 ± 1.54 | 0.478 | 0.652 |
| 4. Convenience | 4.55 ± 1.04 | 5.45 ± 0.93 | 0.040a | 4.09 ± 1.45 | 4.36 ± 1.03 | 0.699 | 0.171 |
| 5. Flexibility | 4.27 ± 1.35 | 5.09 ± 1.14 | 0.151 | 4.27 ± 1.42 | 4.36 ± 1.03 | 1.000 | 0.076 |
| 6. Understanding | 4.64 ± 1.12 | 4.18 ± 1.17 | 0.365 | 4.27 ± 1.27 | 4.36 ± 0.81 | 1.000 | 0.217 |
| 7. Recommend | 4.64 ± 1.29 | 4.64 ± 1.03 | 0.949 | 4.09 ± 1.58 | 4.09 ± 1.64 | 0.949 | 1.000 |
| 8. Continue | 5.00 ± 1.10 | 5.27 ± 1.19 | 0.519 | 4.73 ± 1.27 | 4.36 ± 1.03 | 0.365 | 0.116 |
| Total score of 2 and 3 | 4.55 ± 3.05 | 4.09 ± 3.08 | 0.699 | 4.18 ± 2.71 | 5.36 ± 1.50 | 0.116 | 0.217 |
| Total score of 1, 4, 5, 6, 7, and 8 | 28.45 ± 3.93 | 30.00 ± 5.60 | 0.171 | 26.27 ± 7.07 | 26.36 ± 3.98 | 0.652 | 0.365 |
| Eating behavior | |||||||
| Total (%) | 36.31 ± 19.13 | 37.11 ± 19.49 | 0.519 | 39.16 ± 20.67 | 39.45 ± 21.05 | 1.000 | 0.519 |
Data are expressed as the mean ± standard deviation
(1) p1 value for the intragroup comparison (pre- vs. post-treatment values in the dulaglutide or liraglutide group; ap < 0.05)
(2) p2 value for the intergroup comparison (changes from pre- to post-treatment in the dulaglutide vs. liraglutide group; ap < 0.05)